kaya reported a 14% year-on-year increase in revenue from operations to ₹60.14 crore (₹6013.56 lakh) for the quarter ended June 30, 2026 (Q1FY27), driven by a 16% growth in its clinic business. Despite the top-line expansion, the company posted a standalone net loss of ₹15.18 crore (₹1517.91 lakh), a slight widening from the ₹14.07 crore (₹1406.54 lakh) loss in Q1FY26, primarily due to regulatory changes in input tax credit availability under GST 2.0.

The financial results were reviewed by the Audit Committee and approved by the Board on August 03, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory auditors, B S R & Co. LLP, issued an unmodified limited review report on the unaudited financial results pursuant to Regulation 33. Concurrently, the Board approved a leadership transition effective November 1, 2026, where Harsh Mariwala will move to Non-Executive Director and Chairman, while Rishabh Mariwala assumes the role of Managing Director for a five-year term.

Segment-Wise Growth

The company highlighted robust performance across its key service and product verticals. The clinic business, which includes services, registered a 16% revenue growth over Q1FY26. This was fueled by demand in categories such as Brightening & Pigmentation, Acne & Scars, and Anti-Aging. The skin care business witnessed a 19% growth, while the hair care segment grew by 17%. Additionally, the product business registered a 16% increase, driven by Nutraceutical, Lighter and Brighter, and Anti-Aging categories.

Financial Performance

Total income for the quarter stood at ₹61.27 crore (₹6127.23 lakh). Employee benefits expense remained stable at ₹17.07 crore (₹1707.46 lakh), while finance costs increased slightly to ₹9.34 crore (₹933.56 lakh). Depreciation and amortisation expenses were recorded at ₹10.84 crore (₹1083.58 lakh). Other income decreased to ₹1.14 crore (₹113.67 lakh) from ₹2.00 crore (₹200.04 lakh) in the preceding quarter.

What the Numbers Show

The quarter-on-quarter improvement in net loss is largely attributable to the absence of exceptional items that impacted Q4FY26. In the previous quarter, the company recognized an impact of Labour Codes amounting to ₹3.74 crore (₹374.13 lakh) and an impairment loss of ₹11.77 crore (₹1176.58 lakh) on Property, Plant and Equipment. No such exceptional items were recorded in Q1FY27. However, the year-on-year widening of the loss reflects the operational headwind from GST 2.0 changes effective September 2025, which restricted input tax credit availability. The company continues to operate under a going concern basis, supported by promoter group backing, despite maintaining a negative net worth position as of June 30, 2026.

Kaya Limited has confirmed that Om Prakash Manchanda ceased to serve as an Independent Director on August 02, 2026, following the completion of his first consecutive term of five years. The departure marks the end of a significant governance cycle for the Mumbai-based wellness and healthcare services provider, with the Board of Directors formally acknowledging his tenure and contributions to the company’s strategic direction.

The intimation was issued to the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms that Manchanda’s cessation is effective from the end of the day on August 02, 2026. The disclosure also references compliance with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026, ensuring all regulatory requirements for director changes are met.

Tenure and Contributions

Manchanda, identified by Director Identification Number (DIN) 02099404, served his full initial term without interruption. The Board of Directors and the Management of Kaya Limited have placed on record their sincere appreciation for his valuable guidance, support, and significant contributions during his time with the company. His exit does not appear to be linked to any controversy or performance issue, but rather represents a standard procedural conclusion of a statutory director term.

Regulatory Disclosures

The company provided specific details regarding the change in board composition in Annexure A of its exchange filing. The key particulars are outlined below:

The filing was digitally signed by Brijesh Goyal, Chief Financial Officer of Kaya Limited, on August 03, 2026. As per standard corporate governance practices, the company is expected to initiate the process of appointing a new Independent Director to fill the vacancy, subject to shareholder approval and regulatory norms, although no specific timeline or candidate details were disclosed in this immediate notification.